TY - JOUR
T1 - Clinical experience with a new bicarbonate (25 mmol/L)/lactate (10 mmol/L) peritoneal dialysis solution
AU - Otte, Kjeld
AU - Gonzales, Maria Theresa
AU - Bajo, Maria Auxilliadora
AU - del Peso, Gloria
AU - Heaf, James
AU - Garcia Erauzkin, Gorka
AU - Sanchez Tomero, Jose A.
AU - Dieperink, Hans
AU - Povlsen, Johan
AU - Hopwood, Alexandra M.
AU - Divino Filho, Jose C.
AU - Faict, Dirk
PY - 2003/1/1
Y1 - 2003/1/1
N2 - Objective: Physiological bicarbonate/lactate-based solutions may correct acidosis in a better way than standard lactate-based solutions. In this study, a new 25 mmol/L bicarbonate/10 mmol/L lactate peritoneal dialysis (PD) solution was compared with a standard 35 mmol/L lactate solution. Design: This was a prospective open label study. All patients had a 2-week baseline period using the standard lactate solution, followed by 8 weeks on the bicarbonate/lactate solution and 2 weeks on the lactate-based solution. Setting: Four Danish and four Spanish nephrology centers. Patients: 40 well-dialyzed (creatinine clearance > 55 L/week/1.73 m2 body surface area) patients on continuous ambulatory PD. Interventions: Blood samples were taken for biochemistry (including venous blood gases) at week -2, day 1, weeks 2, 4, and 8, and at follow-up. A physical examination, a peritoneal equilibration test (PET), and quality of life (K/DQOL), ultrafiltration, and adequacy assessments were performed at baseline and at week 8. Vital signs and other safety parameters were followed at each visit. Extraneal (Baxter Healthcare, Castlebar, Ireland) was used by all patients for the long dwell. Main outcome measure: Effect on the venous plasma bicarbonate level. Results: Venous plasma bicarbonate levels rose from 24.4 mmol/L when patients were on the pure lactate to 26.1 mmol/L when using the bicarbonate/lactate solution (p < 0.001). When patients were using the bicarbonate/lactate solution, 66% of values were maintained within the various normal range of 24-30 mmol/L, versus 46.2% when patients were on the pure lactate solution (p < 0.001). There were no adverse findings with respect to clinical symptoms, vital signs, or physical examination. The PET and adequacy, ultrafiltration, and K/DQOL assessment results were unchanged. Conclusions: The new 25 mmol/L bicarbonate/10 mmol/L lactate solution provided better correction of acidosis than an equivalent 35 mmol/L standard lactate solution, without any safety issues.
AB - Objective: Physiological bicarbonate/lactate-based solutions may correct acidosis in a better way than standard lactate-based solutions. In this study, a new 25 mmol/L bicarbonate/10 mmol/L lactate peritoneal dialysis (PD) solution was compared with a standard 35 mmol/L lactate solution. Design: This was a prospective open label study. All patients had a 2-week baseline period using the standard lactate solution, followed by 8 weeks on the bicarbonate/lactate solution and 2 weeks on the lactate-based solution. Setting: Four Danish and four Spanish nephrology centers. Patients: 40 well-dialyzed (creatinine clearance > 55 L/week/1.73 m2 body surface area) patients on continuous ambulatory PD. Interventions: Blood samples were taken for biochemistry (including venous blood gases) at week -2, day 1, weeks 2, 4, and 8, and at follow-up. A physical examination, a peritoneal equilibration test (PET), and quality of life (K/DQOL), ultrafiltration, and adequacy assessments were performed at baseline and at week 8. Vital signs and other safety parameters were followed at each visit. Extraneal (Baxter Healthcare, Castlebar, Ireland) was used by all patients for the long dwell. Main outcome measure: Effect on the venous plasma bicarbonate level. Results: Venous plasma bicarbonate levels rose from 24.4 mmol/L when patients were on the pure lactate to 26.1 mmol/L when using the bicarbonate/lactate solution (p < 0.001). When patients were using the bicarbonate/lactate solution, 66% of values were maintained within the various normal range of 24-30 mmol/L, versus 46.2% when patients were on the pure lactate solution (p < 0.001). There were no adverse findings with respect to clinical symptoms, vital signs, or physical examination. The PET and adequacy, ultrafiltration, and K/DQOL assessment results were unchanged. Conclusions: The new 25 mmol/L bicarbonate/10 mmol/L lactate solution provided better correction of acidosis than an equivalent 35 mmol/L standard lactate solution, without any safety issues.
KW - Acidosis
KW - Alkalosis
KW - Bicarbonate
KW - Bicarbonate/lactate
KW - Biocompatibility
KW - Hypermagnesemia
KW - Lactate
UR - http://www.scopus.com/inward/record.url?scp=0037356174&partnerID=8YFLogxK
U2 - 10.1177/089686080302300208
DO - 10.1177/089686080302300208
M3 - Article
C2 - 12713080
AN - SCOPUS:0037356174
SN - 0896-8608
VL - 23
SP - 138
EP - 145
JO - Peritoneal Dialysis International
JF - Peritoneal Dialysis International
IS - 2
ER -